000 | 01256 a2200325 4500 | ||
---|---|---|---|
005 | 20250515125653.0 | ||
264 | 0 | _c20080902 | |
008 | 200809s 0 0 eng d | ||
022 | _a1744-764X | ||
024 | 7 |
_a10.1517/14740338.7.4.435 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBernardo, Carmina G | |
245 | 0 | 0 |
_aSafety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders. _h[electronic resource] |
260 |
_bExpert opinion on drug safety _cJul 2008 |
||
300 |
_a435-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aBrain Injuries _xcomplications |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aEpilepsy _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
650 | 0 | 4 |
_aNervous System Diseases _xcomplications |
650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
650 | 0 | 4 |
_aStroke _xcomplications |
700 | 1 | _aSingh, Vivek | |
700 | 1 | _aThompson, Peter M | |
773 | 0 |
_tExpert opinion on drug safety _gvol. 7 _gno. 4 _gp. 435-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14740338.7.4.435 _zAvailable from publisher's website |
999 |
_c18095401 _d18095401 |